BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pathology News - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.pathologynews.com
X-WR-CALDESC:Events for Pathology News
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20250101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=UTC:20260303T140000
DTEND;TZID=UTC:20260303T150000
DTSTAMP:20260828T110608
CREATED:20260220T113919Z
LAST-MODIFIED:20260225T133754Z
UID:100118825-1772546400-1772550000@www.pathologynews.com
SUMMARY:Analysis of computational tumor-infiltrating lymphocytes in breast cancer from the results of the TIGER challenge
DESCRIPTION:0000Days00Hrs00Min00SecThe Tissue Image Analytics (TIA) Centre hosts a seminar series for those interested in computational pathology. The series invites researchers and leaders in computational pathology and related fields to present their work and foster thought-provoking discussions. \nThis seminar features Mart van Rijthoven\, Radboud UMC\, Nijmegen\, The Netherlands. \nAbstract\nTumor-infiltrating lymphocytes (TILs) is a recognized prognostic biomarker in breast cancer. However\, poor interobserver agreement and limited reproducibility highlight the need for computational approaches. Despite advances\, adoption of computational models has been hindered by lack of standardized methods and robust benchmarks. To address this\, we launched TIGER\, an international competition to build open-source computational TILs (cTILs) models. Here\, we present a multi-centric analysis of cTILs methods on resections and biopsies from 3\,708 human epidermal growth factor receptor 2-positive (HER2+) and triple-negative breast cancers (TNBC) from clinical practice and phase 3 trials. We report benchmarks on image analysis performance\, show strong agreement of cTILs with pathologists\, and demonstrate positive association of cTILs with neoadjuvant therapy response in HER2+\, superior to visually scored TILs. We also show that cTILs add independent prognostic information to clinical variables in TNBC resections. Data\, methods and benchmarks are publicly available: https://tiger.grand-challenge.org/ \nRegister NowBio\nMart van Rijthoven did his PhD work in the Computational Pathology Group at Radboud University Medical Center\, focusing on deep learning for biomarker quantification in whole-slide images. His work includes the HookNet model\, quantification of tertiary lymphoid structures\, and few-shot learning for histopathology. He also developed the WholeSlideData package and co-organized the TIGER challenge.
URL:https://www.pathologynews.com/event/analysis-of-computational-tumor-infiltrating-lymphocytes-in-breast-cancer-from-the-results-of-the-tiger-challenge/
CATEGORIES:Live Online Webinar
ATTACH;FMTTYPE=image/png:https://www.pathologynews.com/wp-content/uploads/2026/02/TIA-Centre-Seminar-Series-Analysis-of-computational-tumor-infiltrating-lymphocytes-in-breast-cancer-from-the-results-of-the-TIGER-challenge.png
END:VEVENT
END:VCALENDAR